Research news
- NIH launches collaborative program with industry and researchers
- 3 May 2012
- Axerion Therapeutics and AstraZeneca to Develop and Commercialize a Biologic Approach for the Treatment of Alzheimer’s Disease
- 1 May 2012
- AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout
- 23 April 2012
- Conformetrix and AstraZeneca sign collaborative agreement
- 16 April 2012
From bench top to laptop: How scientists are using social media
We recently surveyed our scientists and their external colleagues to find out how they’re using social media for science. The results show they believe there is value, with many using it for information sharing, collaboration, knowledge building and networking.
Discover Partnering with AstraZeneca
AstraZeneca works in partnership with bio companies, academic institutions, governments and not-for-profit organisations, sharing skills, knowledge and resources to achieve a common goal: improved health.
Nobel Laureate Peter Charles Doherty visit to IISc
You can now watch the highlights of AZ & NMI’s collaboration to bring the 1996 Nobel Laureate in Physiology to Bangalore’s Indian Institute of Science.
AstraZeneca joins collaborative programme to share compounds
Mike Poole discusses AZ’s new approach to neuroscience research
In a video message, AZ's Mike Poole discusses how the company will approach neuroscience research in a new and flexible way. Also, Menelas Pangalos reaffirm's AZ's commitment to researching neuroscience with a set of Q&As.
Collaboration with Axerion Therapeutics
Watch the video
Read Q&As